You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

indacaterol

Showing 1 - 25 of 147
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Exercise Performance Trial in Copenhagen (Indacaterol and Mometasonefluroate (low dose), Placebo, Indacaterol and

Recruiting
  • Exercise Performance
  • Indacaterol and Mometasonefluroate (low dose)
  • +2 more
  • Copenhagen, Denmark
    August Krogh Building
Oct 4, 2023

Healthy Volunteers Trial in Helsinki (Indacaterol/glycopyrronium)

Completed
  • Healthy Volunteers
  • Helsinki, Finland
    CRST Helsinki Oy
Jul 12, 2022

Exercise Performance Trial in Copenhagen (Vilanterol and Fluticasone Furoate, Indacaterol and Mometasone Furoate, Placebo)

Recruiting
  • Exercise Performance
  • Vilanterol and Fluticasone Furoate
  • +2 more
  • Copenhagen, Denmark
    August Krogh Building
Oct 4, 2023

COPD Trial in Mexico, City (Indacaterol, Tiotropium)

Completed
  • COPD
  • Mexico, City, Mexico
    Instituto Nacional de Enfermedades Respiratorias, "Ismael Cosío
Aug 16, 2022

Asthma Trial (QVM149, Salmeterol Xinafoate / Fluticasone Propionate, Placebo to QVM149)

Not yet recruiting
  • Asthma
  • (no location specified)
Mar 18, 2023

Asthma Trial (QMF149, Budesonide)

Not yet recruiting
  • Asthma
  • (no location specified)
Nov 22, 2022

COPD Trial (HRG2005 inhalation, Placebo to match HRG2005 inhalation, Placebo to match Indacaterol Maleate and Glycopyrronium

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • HRG2005 inhalation
  • +3 more
  • (no location specified)
Sep 7, 2023

Healthy Volunteers Trial in Helsinki (Indacaterol maleate and glycopyrronium bromide, Ultibro Breezhaler with oral charcoal)

Completed
  • Healthy Volunteers
  • Indacaterol maleate and glycopyrronium bromide
  • Ultibro Breezhaler with oral charcoal
  • Helsinki, Finland
    CRST Helsinki Oy
Sep 27, 2021

Asthma Trial in Nagykanizsa, George, Cape Town (Mometasone furoate, QMF149)

Completed
  • Asthma
  • Nagykanizsa, Hungary
  • +2 more
May 16, 2022

Characterize Patients Initiating Enerzair® Breezhaler®, With or

Withdrawn
  • Asthma
  • IND/GLY/MF
  • (no location specified)
Mar 22, 2022

Asthma Trial in Ottawa, Montreal (Indacaterol maleate, Placebo)

Completed
  • Asthma
  • Indacaterol maleate
  • Placebo
  • Ottawa, Ontario, Canada
  • +1 more
Dec 16, 2020

Asthma Trial in London (QVM149, High Dose Dual Therapy (ICS/LABA))

Withdrawn
  • Asthma
  • QVM149
  • High Dose Dual Therapy (ICS/LABA)
  • London, Ontario, Canada
    Robarts Research Insitute; The University of Western Ontario; Lo
Nov 29, 2021

COPD Trial in Besançon (Indacaterol, Glycopyrronium, Tiotropium)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Indacaterol
  • +4 more
  • Besançon, France
    Centre Hospitalier Régional Universitaire
Aug 2, 2021

Asthma Trial in United States (Indacaterol maleate, Indacaterol acetate, Placebo)

Completed
Has Results
  • Asthma
  • Indacaterol maleate
  • +2 more
  • North Dartmouth, Massachusetts
  • +5 more
Dec 9, 2020

Heart Failure Trial in Milano (Indacaterol, Placebo)

Completed
  • Heart Failure
  • Indacaterol
  • Placebo
  • Milano, MI, Italy
    Centro Cardiologico Monzino
Jan 22, 2020

Asthma, Allergic Asthma Trial (QVM149, QMF149)

Unknown status
  • Asthma
  • Allergic Asthma
  • (no location specified)
Feb 4, 2020

Asthma Trial in Worldwide (Indacaterol acetate 75 µg, Indacaterol acetate 150 µg)

Completed
Has Results
  • Asthma
  • Indacaterol acetate 75 μg
  • Indacaterol acetate 150 μg
  • Brugge, Belgium
  • +28 more
Jan 15, 2020

Inhalative Therapy in Real- Life Conditions

Active, not recruiting
  • Asthma
  • MF/IND/GLY plus sensor system
  • FDC therapy
  • Ulm, BW, Germany
  • +25 more
Aug 10, 2022

COPD Trial in St-Charles-Borromée (Glycopyrronium /Indacaterol maleate)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Glycopyrronium /Indacaterol maleate
  • St-Charles-Borromée, Quebec, Canada
    Novartis Investigative Site
Jun 25, 2019

COPD (COPD) Trial in Bordeaux (Seretide® Diskus® 500/550 µg, Ultibro® Breezhaler® 110/50 µg, Spiriva® Respimat® 2,5 µg)

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Seretide® Diskus® 500/550 μg
  • +2 more
  • Bordeaux, France
    CIC-P - Centre François Magendie - G3 - Hôpital Haut-Lévêque
Feb 8, 2022

COPD (COPD) Trial in Parma (drug, procedure, other)

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • CHF 5993 + Ultibro matched placebo
  • +6 more
  • Parma, Italy
    Chiesi Farmaceutici S.p.A.
Oct 28, 2021

A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS

Recruiting
  • Asthma
  • Atectura inhalation capsule (150/80ug)
  • +2 more
  • Gwangju, Korea, Republic of
    Novartis Investigative Site
Sep 5, 2022

Study to Evaluate the Risk of Cardiovascular Endpoints

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Aclidinium bromide
  • Other COPD medication
  • London, United Kingdom
    Clinical Practice Research Datalink
Jan 30, 2023

COPD Trial in Kingston, Montreal, Quebec (Ultibro®, Spiriva®)

Completed
  • COPD
  • Kingston, Ontario, Canada
  • +2 more
Jun 6, 2019

COPD Trial in Beijing, Zhengzhou (LABA based treatment: indacaterol, LAMA based treatment: tiotropium, LABA/ICS based treatment:

Completed
Has Results
  • COPD
  • LABA based treatment: indacaterol
  • +5 more
  • Beijing, China
  • +1 more
Aug 27, 2019